Table 3 Comparison in laboratory results between patients with plaque regression and progression

WBC (cells/μl)

9323 ± 3443

9635 ± 1878

0.5

Max CK (IU/L)

1852 ± 1993

1717 ± 1629

0.7

Hb (g/dL)

14.1 ± 1.6

13.7 ± 1.9

0.3

AST (IU/L)

80.2 ± 102.8

79.2 ± 86.9

0.96

ALT (IU/L)

33.9 ± 22.5

35.2 ± 22.4

0.8

γ-GTP (IU/L)

45.7 ± 52.3

57.2 ± 68.3

0.4

Total bilirubin (mg/dL)

0.8 ± 0.3

0.8 ± 0.3

0.2

BUN (mg/dL)

15.3 ± 4.9

15.4 ± 5.2

0.9

Creatinine (mg/dL)

0.81 ± 0.24

0.83 ± 0.19

0.7

Uric acid (mg/dL)

5.4 ± 1.6

5.1 ± 1.7

0.4

TC (mg/dL)

196.1 ± 36.5

196.3 ± 35.4

0.98

LDL-C (mg/dL)

132.1 ± 33.3

131.4 ± 34.0

0.9

TG (mg/dL)

115.2 ± 53.0

115.1 ± 24.0

0.99

HDL-C (mg/dL)

44.0 ± 10.3

45.7 ± 8.8

0.4

RLP-C (mg/dL)

4.2 ± 2.3

4.0 ± 2.3

0.6

hs-CRP(mg/L)

32.8 ± 39.0

48.8 ± 43.9

0.08

FBS (mg/dL)

153.6 ± 61.8

156.9 ± 63.8

0.8

HbA1c (%)

6.3 ± 1.2

6.9 ± 1.7

0.023

AGEs (U/mL)

8.4 ± 2.2

9.4 ± 1.9

0.032

sRAGE (pg/mL)

683 (496–1037)

723 (483–1081)

0.9